Author:
Blanco Echevarría Agustín,García Díaz Juan De Dios,Caixas Assumpta,Plana Gil Núria,Rico Corral Miguel Ángel,Bridges Ian,Dhalwani Nafeesa,Gatell Menchen Sònia,Ray Kausik K.
Reference28 articles.
1. Evolocumab and clinical outcomes in patients with cardiovascular disease;Sabatine;N Engl J Med,2017
2. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis;Silverman;JAMA,2016
3. Pharmaceutical strategies for reducing LDL-C and risk of cardiovascular disease;Catapano;Atheroscler Suppl,2019
4. Ministerio de Sanidad, Spain. Facts and figures on health in Spain [Internet]. Ministerio de Sanidad, Spain. 2003. Available from: https://www.sanidad.gob.es/en/organizacion/sns/docs/datos.pdf [cited 1.12.22].
5. World Health Organisation. Cardiovascular diseases. 2021. https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1.